Search

everythinglearnresearchcommunity

for

Search:↓

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

A rare ovarian tumor can occur without causing male-like symptoms.

A new method measures mouse hair loss using shades of gray.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

The new scalp coverage scoring method accurately measures hair loss and growth in men.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Estrogen is important for keeping adult mouse nipple skin healthy by controlling certain cell signals.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Proton minibeam radiotherapy shows promise for sparing healthy tissue in cancer treatment but needs further research and technological development.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Photoepilation significantly reduces hair, and phototrichograms can objectively measure its effectiveness.

New imaging techniques show testosterone delays hair growth and shrinks follicles in mice, but have limited depth for viewing.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Non-invasive imaging techniques improve scalp condition diagnosis and patient quality of life.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Tamoxifen caused hair loss in a 52-year-old woman.

Sweden's forensic medicine is expanding the use of CT and aims to integrate 3D photogrammetry for injury documentation.

The malignant pilomatricoma showed strong epithelial keratin expression, suggesting it may not calcify.

Proton minibeam radiotherapy may reduce skin side effects by causing localized DNA damage.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Hair mass index is a precise way to measure hair loss in chemotherapy patients.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.